References
- Song F, Parekh S, Hooper L, et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010;14:1-220
- World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA 2013;310:2191-4
- European Federation of Pharmaceutical Industries and Associations. Joint principles for responsible clinical trial data sharing. 2013. Available at: http://transparency.efpia.eu/responsible-data-sharing [Last accessed 11 July 2017]
- European Union. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. Official J Eur Union 2014;L158:1-76
- World Health Organization. WHO Statement on Public Disclosure of Clinical Trial Results. April 2015. Available at: http://www.who.int/ictrp/results/reporting [Last accessed 11 July 2017]
- International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. Updated December 2016. Available at: http://www.icmje.org/recommendations/ [Last accessed 11 July 2017]
- Zarin DA, Tse T, Williams RJ, Carr S. Trial reporting in ClinicalTrials.gov – the final rule. N Engl J Med 2016;375:1998-2004
- Rawal B, Deane BR. Clinical trial transparency: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved recently in Europe. Curr Med Res Opin 2014;30:395-405
- Rawal B, Deane BR. Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2012. Curr Med Res Opin 2015;31:1431-5
- Deane BR, Sivarajah J. Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2013. Curr Med Res Opin 2017;33:473-8
- Zarin DA, Tse T, Williams RJ, Rajakannan T. Update on trial registration 11 years after the ICMJE policy was established. N Engl J Med 2017;376:383-91
- van Valkenhoef G, Loane RF, Zarin DA. Previously unidentified duplicate registrations of clinical trials: an exploratory analysis of registry data worldwide. Syst Rev 2016;5:116
- Rawal B, Deane BR. Clinical trial transparency and the evaluation of new medicines. Clin Invest 2014;4:587-90
- Bashir R, Bourgeois FT, Dunn AG. A systematic review of the processes used to link clinical trial registrations to their published results. Syst Rev 2017;6:123
- Powell-Smith A, Goldacre B. The TrialsTracker: automated ongoing monitoring of failure to share clinical trial results by all major companies and research institutions. F1000Research 2016;5:2629
- Mooney LA, Fay L. Cross-sectional study of Pfizer-sponsored clinical trials: assessment of time to publication and publication history. BMJ Open 2016;6:e012362
- Evoniuk G, Mansi B, DeCastro B, Sykes J. Impact of study outcome on submission and acceptance metrics for peer reviewed medical journals: six year retrospective review of all completed GlaxoSmithKline human drug research studies. BMJ 2017;357:j1726
- Academy of Medical Science report. Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines. June 2017. Available at: https://acmedsci.ac.uk/file-download/44970096 [Last accessed 11 July 2017]